Johnson & Johnson JNJ
NYSE JNJ
$269.99 -0.22 (-0.08%)
At close: Sep 18, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Treasury Shares (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Treasury Shares came in at $75.9 billion in Q2 2026, up 3466.67% year-over-year from $2.1 billion in Q2 2025, and down 0.53% quarter-over-quarter from $76.3 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Treasury Shares (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Treasury Shares across 18 years of filings, most recently posting $75.9 billion for Q2 2026.

  • In Q2 2026, Treasury Shares rose 3466.67% year-over-year to $75.9 billion; the TTM figure through Jun 2026 stood at $75.9 billion (up 3466.67% YoY), while the FY2025 annual figure was $75.6 billion, changed 0.07% from the prior year.
  • Treasury Shares came in at $75.9 billion for Q2 2026 at Johnson & Johnson, down from $76.3 billion in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $714.2 million in Q1 2025 to a low of $490.5 million in Q2 2022.
  • Average Treasury Shares over 5 years is $635.8 million, with a median of $712.5 million recorded in 2024.
  • Year-over-year, Treasury Shares sank 58.88% in 2024 and jumped 3482.15% in 2026.
  • Over 5 years, Treasury Shares stood at $4.7 billion in 2022, then soared by 1504.71% to $75.7 billion in 2023, then increased by 0.02% to $75.7 billion in 2024, then declined by 0.07% to $75.6 billion in 2025, then gained by 0.32% to $75.9 billion in 2026.
  • Per Business Quant data, the three most recent Treasury Shares figures were $75.9 billion in Q2 2026, $76.3 billion in Q1 2026, and $75.6 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 711.62 Mn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 77.11 Mn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 1.11 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -49.00 Mn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 3.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 880.00 Mn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 711.62 Mn
Jun 28, 2026 711.62 Mn
Jun 28, 2026 75.86 Bn
Jun 28, 2026 75.86 Bn
Mar 29, 2026 76.26 Bn
Mar 29, 2026 713.26 Mn
Mar 29, 2026 76.26 Bn
Mar 29, 2026 713.26 Mn
Dec 28, 2025 75.62 Bn
Dec 28, 2025 711.90 Mn
Dec 28, 2025 75.62 Bn
Dec 28, 2025 711.90 Mn
Sep 28, 2025 75.89 Bn
Sep 28, 2025 75.89 Bn
Sep 28, 2025 713.65 Mn
Sep 28, 2025 713.65 Mn
Jun 29, 2025 713.06 Mn
Jun 29, 2025 713.06 Mn
Jun 29, 2025 2.13 Bn
Jun 29, 2025 2.13 Bn